Skip to main content
Orphanet Journal of Rare Diseases logoLink to Orphanet Journal of Rare Diseases
. 2024 Mar 28;19:139. doi: 10.1186/s13023-024-03140-x

Correction: A review and recommendations for oral chaperone therapy in adult patients with Fabry disease

Michał Nowicki 1,, Stanisława Bazan‑Socha 2, Beata Błażejewska‑Hyżorek 3, Mariusz M Kłopotowski 4, Monika Komar 5, Mariusz A Kusztal 6, Tomasz Liberek 7, Jolanta Małyszko 8, Katarzyna Mizia‑Stec 9, Zofia Oko‑Sarnowska 10, Krzysztof Pawlaczyk 11, Piotr Podolec 5, Jarosław Sławek 12; the Polish Fabry Disease Collaborative Group
PMCID: PMC10976668  PMID: 38549140

Correction : Orphanet J Rare Dis (2024) 19:16

https://doi.org/10.1186/s13023-024-03028-w

Following publication of the original article [1], we have been notified that there was a mistake in the body text of the article.

It is now:

Polish experience with migalastat therapy

At the end of December 2024, 32 FD patients are treated with migalastat in Poland, and none was discontinued.

It should be:

Polish experience with migalastat therapy

At the end of December 2023, 32 FD patients are treated with migalastat in Poland, and none was discontinued.

Reference

  • 1.Nowicki, et al. A review and recommendations for oral chaperone therapy in adult patients with Fabry disease. Orphanet J Rare Dis. 2024;19:16. doi: 10.1186/s13023-024-03028-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Orphanet Journal of Rare Diseases are provided here courtesy of BMC

RESOURCES